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Background: Dengue is an arboviral disease caused by dengue virus (DENV), whose main vectors are the
mosquitoes Aedes aegypti and Aedes albopictus. A. aegypti is the only DENV vector in Cape Verde, an African country
that suffered its first outbreak of dengue in 2009. However, little is known about the variation in the level of vector
competence of this mosquito population to the different DENV serotypes. This study aimed to evaluate the vector
competence of A. aegypti from the island of Santiago, Cape Verde, to four DENV serotypes and to detect DENV
vertical transmission.
Methods: Mosquitoes were fed on blood containing DENV serotypes and were dissected at 7, 14 and 21 days
post-infection (dpi) to detect the virus in the midgut, head and salivary glands (SG) using RT-PCR. Additionally, the
number of copies of viral RNA present in the SG was determined by qRT-PCR. Furthermore, eggs were collected in
the field and adult mosquitoes obtained were analyzed by RT-PCR and the platelia dengue NS1 antigen kit to
detect transovarial transmission.
Results: High rates of SG infection were observed for DENV-2 and DENV-3 whereas for DENV-1, viral RNA was only
detected in the midgut and head. DENV-4 did not spread to the head or SG, maintaining the infection only in the
midgut. The number of viral RNA copies in the SG did not vary significantly between DENV-2 and DENV-3 or among
the different periods of incubation and the various titers of DENV tested. With respect to DENV surveillance in
mosquitoes obtained from the eggs collected in the field, no samples were positive.
Conclusion: Although no DENV positive samples were collected from the field in 2014, it is important to highlight
that the A. aegypti population from Santiago Islands exhibited different degrees of susceptibility to DENV serotypes.
This population showed a high vector competence for DENV-2 and DENV-3 strains and a low susceptibility to
DENV-1 and DENV-4. Viral RNA copies in the SG remained constant for at least 21 dpi, which may enhance the
vector capacity of A. aegypti and suggests the presence of a mechanism modulating virus replication in the SG.
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Dengue is considered one of the most important arbo-
viral infections in the world. Currently, it is estimated
that 3.6 billion people live in tropical and subtropical
areas where dengue is endemic. Approximately 50 to
200 million infections occur annually, resulting in
500,000 cases of dengue hemorrhagic fever (DHF) and
more than 20,000 deaths [1,2].
Dengue is caused by a flavivirus named Dengue virus
(DENV), which is transmitted to humans by mosquitoes
of the genus Aedes, principally Aedes aegypti and Aedes
albopictus [3]. This virus comprises different serotypes
that evolved in nonhuman primates from a common an-
cestor and entered the urban cycle approximately 100–
1500 years ago [4]. Despite the vast knowledge of the
virus and the great epidemiological importance of this
disease, there are currently no specific antiviral therapies
or commercially available vaccines against all serotypes
of DENV, which limits the prevention of viral transmis-
sion to vector control.
A. aegypti is the main vector of DENV in most countries
where dengue is endemic [5]. This mosquito originated in
Africa but is currently widely distributed across tropical
and subtropical regions of Africa, Asia, Australia, the
South Pacific, Americas and parts of the Middle East [5,6].
According to Gubler [7], increased geographical distribu-
tion of A. aegypti has been the main cause of DENV dis-
semination in the world.
Natural populations of A. aegypti exhibit genetic vari-
ation that can be responsible for various degrees of sus-
ceptibility to dengue virus infection [8-10]. The ability of
the vector to be infected by a pathogen, allowing it to
replicate and transmit it to another host, is called vector
competence [10]. Vector competence is mainly influ-
enced by the genetic variability of the vector and the
pathogen; however, it is sometimes modulated by envir-
onmental factors [11,12]. Therefore, variation in A.
aegypti vector competence to DENV observed in differ-
ent natural environments has implications for the virus’s
transmission. Thus, studying this variation is important
for understanding the dynamics of DENV transmission
in different geographical contexts, and the understand-
ing of the mechanisms that modulate this vector compe-
tence can help to develop alternative ways of controlling
vector borne diseases, such as genetically modified mos-
quitoes that are refractory to the virus [12].
Currently, four serotypes of DENV (DENV1-4) co-
circulate in Africa, and most epidemics have been
caused by DENV-2, followed by DENV-1 [13]. The
prevalence of dengue in Africa is low when compared
with that in other endemic regions, which according to
some authors, may in part be due to the lower vector
competence of African strains of A. aegypti, especially
the subspecies A. aegypti formosus [14,15].The first outbreak of dengue fever in Cape Verde oc-
curred in 2009. Cape Verde is an archipelago located
500 km from the West African coast. During the epi-
demic, more than 20,000 cases were reported, with 174
diagnosed as DHF, and four people died [16]. The epi-
demic was caused by a DENV-3 strain, which possibly
originated from neighboring countries on the West
African coast [17].
The presence of A. aegypti in Cape Verde has been re-
corded since 1931 [18], with no records of other species
of Aedes, such as A. albopictus, that could be implicated
in the transmission of DENV [19]. Nevertheless, little is
known about the level of vector competence of local
populations of A. aegypti to DENV. Vazeille et al. [20],
demonstrated that the A. aegypti population from
Santiago Island, Cape Verde, has a moderate ability to
transmit the DENV-3 strain responsible for the 2009
epidemic, but the population exhibited little susceptibil-
ity to the DENV-2 strain isolated from Thailand.
Considering that all four serotypes are present in the
African mainland and that Cape Verde is located in a stra-
tegic route connecting Africa, Europe and the Americas,
by sea or by air, thus presenting a high risk of introduction
of new DENV strains, it is of great interest to know the
status of susceptibility to infection of all serotypes in the
local A. aegypti population in order to implement control
measures in advance to prevent future outbreaks.
Therefore, the present study aimed to evaluate the
vector competence of Aedes aegypti from the island of
Santiago, Cape Verde, to four serotypes of dengue virus
(DENV- 1, DENV- 2, DENV- 3 and DENV- 4) using RT-
PCR and also to survey for DENV serotypes in Aedes
aegypti egg samples collected from the field. Our results
indicate significant variation regarding the mosquito sus-
ceptibility to the four serotypes investigated, which has
important implications to the epidemiology of dengue in
the country.
Methods
Study area, sample collection and establishment of the
Aedes aegypti population
Sample collection was conducted on the island of
Santiago, located in the archipelago of Cape Verde. Cape
Verde is an African country located in the Atlantic Ocean
(17° 12 ′ - 14° 48′ N and 22° 44 ′ - 25° 22′ W), 500 km off
the western coast of Africa [21]. It is composed of ten
islands (Santo Antão, São Vicente, Santa Luzia, São
Nicolau, Sal, Boavista, Maio, Santiago, Fogo and Brava),
with a total area of 4,033 km2, and has 491,683 inhabi-
tants [22].
Santiago is the largest island with an area of 991 km2
and a population of 273,919 inhabitants distributed in
nine counties [22]. Santiago is also home to the country’s
capital, the city of Praia, which is the most populated
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dengue cases were reported during the epidemic of 2009
[16].
For the infections experiments, A. aegypti eggs were
collected using oviposition traps (ovitraps), adapted from
the Fay and Perry model [23], from March to June 2012.
A total of 107 ovitraps were distributed in peridomestic
areas over seven counties of the island close to a variety
of potential breeding sites (wells, tanks and other aquatic
habitats), according to routine entomological surveys
performed by the Ministry of Health of Cape Verde. To
search for natural transovarial DENV transmission, eggs
were collected during January and February 2014 using a
total of 241 ovitraps placed in four sites: Assomada, City
of Praia, Santa Cruz and Tarrafal.
The collected eggs were then transported to the in-
sectary of Centro de Pesquisas Aggeu Magalhães in
Brazil, where they were hatched according to standard
procedures to establish the adult population as described
by Carvalho et al. [24] or stored at −80°C in pools of five
mosquitoes (separated according sex and site of collec-
tion) for the vertical transmission analysis. The insectary
conditions were 70 –80% humidity, a 12 h:12 h light:
dark cycle, and 26 ± 1°C. Infections experiments de-
scribed below were performed with the F1-F3 genera-
tions and vertical transmission analysis in the F0
generation.
Propagation of DENV in the C6/36 cell line
The viral stocks of different DENV serotypes used in this
study were generously provided by the Laboratory of
Virology and Experimental Therapy (LAVITE) from
CPqAM/ Fiocruz-PE, Brazil. The strains used were
DENV-1 42735/BR PE (GenBank Accession N° EU2
59529), DENV-2 3808/BR-PE (EU259569), DENV-3
85469/BR-PE (EU259607) and DENV-4 1385 (U1842).
In previous studies, these strains efficiently infected and
disseminated in Aedes aegypti populations from Recife,
Brazil [25,24].
Viral stocks were propagated in the C6/36 cell line, as
previously described by Carvalho-Leandro et al. [24] and
Xi et al. [26], with modifications. Briefly, 250 μl of virus
stocks was used to infect C6/36 cells (seeded to 80%
confluence) with a multiplicity of infection (MOI) of 0.5
virus particles/cell. The cells were then incubated at
28°C for 5–7 days, until strong cytopathic effects were
observed. Three cycles of freezing and thawing at −80°C
and at 37°C, respectively, were performed to lyse the
cells and release the viral particles. Cells and supernatant
were then mixed 1:1 with defibrinated sheep blood and
used to feed the females. The infected blood was main-
tained at 37°C for 30 minutes prior to feeding the mos-
quitoes. For control experiments, a flask of uninfected
C6/36 cells (no virus) was maintained under similarconditions and used to create a noninfectious blood-
meal. Before feeding, an aliquot of the blood/virus mix-
ture was stored at −80°C for subsequent virus titration,
as described in Santos et al. [27].Mosquito infection
Oral infection was performed in nulliparous 7- to 10-
day-old female mosquitoes using an artificial membrane
feeding system [28]. Approximately 100–150 mosqui-
toes, starved for 24 hours before the experiment, were
fed with blood containing, separately, different DENV
serotypes over 45 minutes. Simultaneously, a control
group of an equal number of individuals was fed with a
noninfectious bloodmeal. After feeding, only engorged
females were transferred to another cage and maintained
under previously described standard conditions for
21 days. Two independent experiments were performed
for each serotype separately.Tissue collection and RNA extraction
Heads, midguts and salivary glands were collected on
the 7th, 14th and 21st day post- infection (dpi). Dissec-
tions were performed in 1X PBS using 15 to 20 mosqui-
toes per time point. After dissections, the tissues were
placed separately in 1.5 ml microtubes containing 250 μl
of mosquito diluent (1X PBS, 0.1 M, pH 7.4, 10% fetal
bovine serum, 1% antibiotic and antifungal agents) [29]
and stored at - 80°C until RNA extraction.
Total RNA extraction was performed using Trizol fol-
lowing the manufacturer’s protocol (Invitrogen Cat. N°
15596–026), and RNAs were further treated with DNase
(Turbo DNase - Ambion, Cat N° AM2239) and stored at -
80°C until further use.Determination of infection rates by One Step RT-PCR
Detection of the virus in the midgut, salivary glands and
head was first performed using One Step RT-PCR and
NS5 primers as reported by Kong et al. [30]: forward,
5′-GGAAGGAGAAGGACTGCACA-3′ and reverse, 5′-
ATTCTTGTGTCCCATCCTGCT-3′.
PCR reactions were performed using 12.5 μl of master
mix (Promega Cat.N° M7505), 10 μM of each primer,
0.1 M DTT, 1.05 U of AMV-RT (Invitrogen), 1.2 U of
RNAase OUT, 500 ng of the sample RNA, and water to
a final volume of 25 μl. Cycling conditions were performed
as follows: 1 cycle at 50°C for 60 minutes, 40 cycles at 94°C
for 1 minute, 55°C for 1 minute, 72°C for 2 minutes and a
final cycle of 72°C for 10 minutes. RT-PCR products were
then analyzed by electrophoresis on a 1.5% agarose gel in
Tris-borate-EDTA (TBE) buffer with ethidium bromide
and visualized on a UV transilluminator.
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qRT-PCR
The quantitative RT-PCR (qRT-PCR) was performed
using the Quantitect SYBR Green RT-PCR Kit (QIA-
GEN, Cat N° 204245) and the same primers NS5F and
NS5R described above for the One Step RT-PCR.
For the PCR reactions, the following were used:
12.5 μl of SYBR Green Master Mix (2X), 0.2 mM of each
primer, 0.25 μl of the reverse transcriptase enzyme
(QIAGEN), 5 μl of each RNA sample (normalized to
50 ng) and ultra-pure water to a final volume of 25 μl.
Amplification reactions were performed in a PCR real-
time system from Applied Biosystems (ABI 7500) pro-
grammed for 1 cycle at 50°C for 30 minutes, 95°C for
15 minutes, 40 cycles at 94°C for 15 seconds, 58°C for
30 seconds, and 72°C for 30 seconds. The number of
viral RNA copies in the salivary glands was determined
by absolute quantification using cycle threshold (ct)
values from a standard curve method included in each
PCR plate. The standard curve consisted of known con-
centration of purified NS5 transcript as described in
Kong et al. [30].
Determination of viral titer in the mixture blood/virus by
plaque assay in C6/36 cells
Virus titration was determined by a focus-forming assay
in C6/36 cells, as described previously by Santos et al.
[27]. Briefly, 3 x 105 C6/36 cells in the L15 medium
(supplemented with 5% fetal bovine serum) were seeded
in a 24-well plate 48 hours before the test. Subsequently,
the cells were incubated with serially diluted virus-
containing blood for 1 hour. The L-15 medium was
removed, and the cells were covered with 1 ml of semi-
solid medium containing carboxymethylcellulose (1%),
L-15 medium (2X concentrate), FBS (2%), and antibiotic
and antifungal agents (1%) and incubated at 28°C for
5 days. After the incubation period, the cells were fixed
with 30% cold acetone in 1X PBS for 13 minutes and
rinsed once with PBS and allowed to dry for 24 hours.
After this period, the cells were incubated for 1 hour at
37°C with the primary antibody (HMAF diluted 1:100 in
ligation buffer). The plates were washed three times with
wash buffer (1X PBS and Tween-20) and incubated with
horseradish peroxidase-conjugated recombinant protein
G (Invitrogen- Cat No. 10–1223) at 37°C for 1 hour.
The plates were rinsed three times with wash buffer; fi-
nally, 500 μl of AEC substrate (Sigma- Cat. N° A6926)
was added, and the plate was incubated until the appear-
ance of foci. Foci were counted, and virus titers are
expressed in focus-forming unit/ml (FFU/ml).
Data analysis
The midgut infection rate, dissemination rate and vec-
tor competence (salivary glands infection rate) weredetermined for each DENV serotype. The midgut in-
fection rate corresponded to the number of mosqui-
toes with infected midgut divided by the total number
of mosquitoes exposed to the virus. The dissemination
rate was determined by the number of mosquitoes with
infected head divided by the total number of mosqui-
toes with infected midgut. The vector competence or
salivary glands (SG) infection rate was defined as the
number of mosquitoes with infected salivary glands di-
vided by the total number of mosquitoes exposed [10].
ANOVA with Dunnett’s post-test and nonparametric
Kruskal Wallis and Mann–Whitney tests were applied
for the comparative analysis, using SigmaPlot Version
12.5 software.
Dengue virus detection through RT-PCR and Platelia
Dengue NS1 Ag kit
Eggs were collected in four sites of the island of Santiago
(Assomada, Praia, Santa Cruz and Tarrafal) and virus de-
tection in adult mosquitoes was performed via RT-PCR
and the platelia dengue NS1 kit. Mosquito pools (up to
5 specimens) were homogenized with a pestle in 500 μl
of Leibovitz medium (L-15) supplemented with 2% Fetal
Bovine Serum (FBS), Penicillin-Streptomycin (1%) and
Fungizon (1%). For RT-PCR assays, viral RNA was ex-
tracted from mosquito samples using Trizol according
to the manufacturer’s protocol. Prior to RT-PCR reac-
tions, the RNAs were treated with TURBO™ DNAse
(Ambion) to avoid genomic DNA contamination. RT-
PCR for detecting and genotyping DENV in mosquito
pools was performed according to Lanciotti et al. [31].
For Platelia Dengue NS1 Ag. (BioRad) assay, fifty micro-
liters (50 μl) of the supernatant of centrifuged mosquito
homogenate suspensions was used. Tests were per-
formed as described in the manufacturer’s protocol.
Results
Infection with DENV-1
DENV-1 was detected in midgut only at 21 dpi, reaching
a midgut infection rate of 13% in the 1st experiment
(viral titer of 5 × 104 FFU/ml) and 27% in the 2nd ex-
periment (2 × 105 FFU/ml) (Table 1).
DENV-1 was detected in the mosquito head at 21 dpi
as well, with a dissemination rate of 100% in the 1st ex-
periment (5 × 104 FFU/ml) and 25% in the 2nd experi-
ment (2 × 105 FFU /ml). Analyses of the salivary glands
(SG) revealed that for both experiments (different titers)
these organs did not become infected with DENV-1 dur-
ing an extrinsic incubation period of 21 days.
Infection with DENV-2
Unlike DENV-1, DENV-2 was detected in the midgut at 7
dpi, reaching infection rates of 50% and 70% in the 1st
(1.4 × 105 FFU/ml) and 2nd experiment (2 × 105 FFU/ml),
Table 1 Midgut infection rate, dissemination rate and vector competence estimated by RT-PCR using NS5 gene for the
Aedes aegypti population from Santiago Island, Cape Verde
Serotype Virus titer
(FFU/mL)










































DENV-1 5.0 × 104 2 × 105 0.0 0.0 13.3 0.0 0.0 26.7 - - 100 - - 25 0.0 0.0 0.0 0.0 0.0 0.0
DENV-2 1.4 × 105 2 × 105 50.0 75.0 75.0 70.0 85.0 60.0 20.0 73.3 93.3 28.6 76.5 91.7 5.0 55.0 65.0 5.0 65.0 35.0
DENV-3 1.0 × 106 2 × 106 10.0 65.0 70.0 15.0 65.0 80.0 50.0 76.9 121.4 66.7 76.9 87.5 5.0 50.0 75.0 0.0 45.0 55.0
DENV-4 1.0 × 106 2 × 106 0.0 0.0 9.0 0.0 0.0 0.0 - - 0.0 - - - 0.0 0.0 0.0 0.0 0.0 0.0
Notes: aMidgut infection rate corresponds to the number of mosquitoes with infected midgut divided by the total number of mosquitoes exposed to the virus.
bDissemination rate corresponds to the number of mosquitoes with infected head divided by the total number of mosquitoes with infected midgut. cThe
vector competence or salivary glands infection rate corresponds to the number of mosquitoes with infected salivary gland divided by the total number of
mosquitoes exposed.
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gut infection rate, reaching 75% and 85% at 14 dpi. At 21
dpi, rates of 75% and 60% were recorded (Table 1).
With respect to the DENV-2 dissemination rates, there
was an increase in the number of positive head samples
during the extrinsic incubation period, reaching a max-
imum of 93.3% and 91.7% at 21 dpi for the 1st (1.4 ×
105 FFU/ ml) and 2nd (2 × 105 FFU/ml) experiments,
respectively (Table 1).
At 7 dpi, the percentages of infected salivary glands
(vector competence) in both experiments were 5%. For
the 1stexperiment, the maximum was 65% at 21 dpi, and
for the second one, it was also 65% but was reached earl-
ier, at 14 dpi.
Infection with DENV-3
Oral infections with DENV-3 were performed with a virus
titer of 1 × 106 FFU/ml (1st experiment) and 2 × 106 FFU/
ml (2nd experiment). At 7 dpi, the midgut infection rates
were 10% and 15%, which increased with the extrinsic in-
cubation period, reaching 70% (for 1 × 106 FFU/ml) and
80% (2 × 106 FFU/ml) at 21 dpi (Table 1). Dissemination
rates of DENV-3 also increased with the extrinsic incuba-
tion period, reaching a maximum of 121% and 88% for the
1st and 2nd experiment, respectively.
Similarly to DENV-2, positive SG were detected at 7 dpi,
but only in the 1st experiment. The maximum rate ob-
served was 75% for the 1st experiment (1 × 106 FFU/ml)
and 55% for the 2nd experiment (2 × 106 FFU/ml).
Infection with DENV-4
DENV-4 titers in the bloodmeal were 1 × 106 and 2 ×
106 FFU/ml (1st and 2nd experiment, respectively).
DENV-4 was only detected in the experiment with the
lowest viral titer (1 x 106 FFU/ml), with a midgut infection
rate of 9% at 21 dpi. For both experiments, DENV-4 was
not detected in the head or the SG of the mosquitoes
(Table 1).Quantification of viral RNA in the salivary glands
With respect to DENV-2, the number of viral RNA copies
in the salivary glands ranged from 2.5 × 106 to 1.8 ×108 in
the 1st experiment and from 1.7 × 106 to 3.0 × 107 RNA
copies/μl in the 2nd experiment (Figure 1). No significant
differences were recorded in the number of copies among
the different time points of the 1st experiment (P = 0.9,
P > 0.05) nor in the 2nd experiment (P = 0.1, P > 0.05).
Comparison between the two experiments also revealed
no significant difference (p > 0.05).
DENV-3 RNA copies ranged from 1.7 × 106 to 4.0 × 107
in the 1st experiment. For the 2nd experiment, DENV-3
RNA copies ranged from 5.5 × 106 to 5.2 × 107 RNA cop-
ies/μl (Figure 1). Likewise, for DENV-2, no significant dif-
ferences were observed in the number of copies among
the different time points in the 1st experiment (P = 0.16,
P > 0.05), nor in the 2nd experiment (P = 0.15, P > 0.05).
Furthermore, no differences between the two experiments
were detected (P > 0.05).
Comparison of the number of copies of viral RNA
from DENV-2 and DENV-3 showed no significant differ-
ence between the two serotypes (P > 0.05).
DENV surveillance in A. aegypti mosquitoes collected
from field-caught eggs
A total of 6,038 eggs were collected in the four sites; 832
eggs from Assomada, 1,825 from the city of Praia, 2,223
from Santa Cruz and 1,158 eggs from Tarrafal. A total of
1,246 mosquito specimens (252 pools) comprising 533
females (108 pools) and 713 males (144 pools) were ana-
lyzed by RT-PCR and for DENV NS1 antigen using the
Platelia Dengue NS1 Ag kit. All pools were negative for
both techniques.
Discussion
This study represents the first evaluation of the vector
competence of the Aedes aegypti population from




















































Figure 1 Quantification of viral RNA copies (DENV-2 and DENV-3) by qRT-PCR detected in the salivary glands of Aedes aegypti collected in
Santiago Island, Cape Verde.
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cording to the results, the Aedes aegypti population has
high vector competence for DENV-2 (3808/BR-PE) and
DENV-3 (85469/BR-PE) but has low susceptibility to
DENV-1 (42735/BR-PE) and DENV-4 (1385).
The DENV-1 strain used in this study was isolated in
Pernambuco State, Brazil, in 1997, and belongs to the
America/Africa genotype [32]. This genotype includes
strains isolated in the Americas, India and Africa that
have large epidemiological impact throughout the world
[33-35]. The transmission of DENV-1 is also common
on the African continent [13]. Until mid-2013, more
than 517 cases of DENV-1 infections were detected in
Angola. Viral genome sequencing revealed that the
DENV strain belongs to the America/Africa genotype
and is closely related to strains circulating in the Ivory
Coast, Abidjan and South America [36]. Additionally,
samples collected from European travelers from 2000 to
2008 showed that strains belonging to the America/Africa
genotype are circulating in the Ivory Coast, Sudan and
Cameroon, thus indicating the epidemiological import-
ance of this genotype in Africa [37].
Despite the importance of this genotype in other
countries, our results showed that the replication of
DENV-1 in the A. aegypti population from Santiago Is-
land was very low, once we were not able to detect virus
particles in the salivary glands (SG), even in mosquitoes
with infected heads, possibly indicating the presence of
an effective SG infection barrier against DENV-1. A pre-
vious infection study using an A. aegypti population
from Recife (Brazil) and the same DENV-1 strain used
in our study reported that the infection of the SG in that
population occurred at 7 dpi [25], which highlights a
large difference in vector competence between the popu-
lation of A. aegypti from Santiago Island and Recife,Brazil. This behavior may help to explain the fact that
DENV-1 has never been isolated in Cape Verde, although
this serotype continues to circulate in many African
countries.
In contrast to what we observed for DENV-1, the popu-
lation from Santiago Island showed a high vector compe-
tence for the DENV-2 serotype. According to Salazar et al.
[28], a short period of extrinsic incubation may have im-
portant consequences on dengue transmission because
the more quickly the virus reaches the SG, the more likely
it is to be transmitted to a host during the vector survival
period. DENV-2 used in the present study is representa-
tive of the Southeast Asian genotype [32]. DENV-2 was
first detected in the Americas during an epidemic in Cuba
in 1981, when thousands of cases of dengue hemorrhagic
fever were documented [38]. Subsequent outbreaks of
DHF emerged in Brazil, Venezuela, Colombia, and Guyana
[39]. Given that the population of A. aegypti from Santiago
Island displayed a high vector competence for Southeast
Asian DENV-2, immediate preventive measures should be
taken if this genotype is detected in Cape Verde or neigh-
boring countries.
Similarly to what was observed for DENV-2, the A.
aegypti population from Santiago exhibited high vector
competence for the DENV-3 strain. This strain was also
isolated in Pernambuco, and phylogenetic studies revealed
that the strain belongs to the sub-continental India geno-
type, according to the classification of Rico-Hesse [32], or
genotype III, according to Chen and Vasilakis’ classifica-
tion [40]. In Africa, DENV-3 was first isolated in 1984 dur-
ing an epidemic of dengue fever in Mozambique [41]. Ten
years later, this serotype was detected in Somalia and near
the Persian Gulf [42] and then expanded to the West
African areas, being isolated in Cameroon (2006), the
Ivory Coast (2008), Senegal and Cape Verde in 2009 [17].
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this study can help us to understand the outbreak re-
ported in 2009 in Cape Verde; however, this genotype
was not subjected to phylogenetic studies, and therefore
is unknown. Vazeille et al. [20] evaluated the vector
competence of A. aegypti from Santiago Island for a
DENV-3 strain isolated in the epidemic of 2009, and the
authors observed rates of dissemination of 80% at 14
dpi. However, analysis of saliva by immunofluorescence
revealed a transmission rate of only 20%, which, accord-
ing to the authors, may indicate the presence of an SG
infection barrier. The use of immunofluorescence in-
stead of qRT-PCR and saliva in place of SG in the
Vazeille et al. study may explain the differences found
relative to the present study. In summary, both studies
corroborated that the A. aegypti population from Cape
Verde is efficient in transmitting DENV-3 despite differ-
ences in the transmission rate. So far, all strains of
DENV-3 detected in East Africa from 1984 to 1993 and
also detected in recent dengue cases in Cameroon, Ivory
Coast and Senegal (West Africa) belonged to genotype
III [17,43], this strain may be the genotype that circu-
lated in Cape Verde at the time of the epidemic.
With respect to DENV-4, the virus replicated less than
the three other serotypes analyzed. This result may sug-
gest that the population of A. aegypti from Santiago
Island has an effective midgut escape barrier (MEB)
against DENV-4, and therefore, the virus could not dis-
seminate to SG.
The DENV-4 strain used in this study is representative
of genotype II [44], being directly associated with strains
of great importance in the Caribbean and South America
[45]. Our results indicate that despite the great dispersal
ability of the DENV-4 genotype II and the intense flow
of people between Santiago Island and Brazil, the island
seems to be at a very low risk of its transmission, due to
the very low susceptibility of the local mosquito popula-
tion to this genotype.
With regard to the different virus titers used in oral in-
fections, the titers mainly affected the midgut infection
rate because the higher DENV titers used for DENV-1,
DENV-2 and DENV-3 resulted in higher rates of midgut
infection. Bennett et al. [10] demonstrated that the virus
titer greatly affects the midgut infection rate. However,
the authors found no relationship between the titer and
the rate of dissemination. In other experiments, Bosio
et al. [46] also found no correlation between the titer of
DENV- 2 in the midgut and the rate of dissemination.
Our results demonstrate that for some viral titers, virus
replication in the head increases, whereas replication in the
midgut decreases throughout the extrinsic incubation
period. This relationship also proved to be important for
vector competence because in the 1st experiment, SG in-
fection rate was higher (75%) compared with the 2ndexperiment (55%). Salazar et al. [28] also found that DENV-
2 replication in the midgut decreases after 10 dpi, whereas
the number of infected heads increased after 14 dpi.
Interestingly, viral RNA quantification results in the
SG revealed that the amount of RNA stayed relatively
constant after reaching these organs and remained con-
stant until the last time point analyzed (21 dpi). This
finding demonstrates that the mosquito maintains its
ability to transmit the pathogen for a period of at least
21 days. Our results also corroborate those of a previous
study where viral RNA quantification in three popula-
tions of A. aegypti from the state of Pernambuco exhib-
ited no significant differences in viral load in the SG
among those populations [24]. According to Salazar
et al. [28], a relatively constant number of RNA copies
could also suggest the existence of some mechanism that
regulates viral replication in the mosquito.
Despite many studies focusing on the vector compe-
tence of Aedes mosquitoes to DENV, the mechanisms that
regulate this trait are not fully understood. Vector compe-
tence appears to be associated with certain barriers to in-
fection, including the midgut infection barrier (MIB), the
midgut escape barrier (MEB) and the SG infection barrier
(SIB) [47]. According to Black et al. [48], the MIB inhibit
the early stages of viral infection, such as binding to recep-
tors, uncoating, transcription and translation, whereas the
MEB may act at the level of the passage through the basal
lamina or maturation of the virus.
Vector competence can also be modulated by environ-
mental factors. Carrington et al. [49] observed that large
temperature fluctuations during the day reduced the rate
of infection of the intestine and increased the period of
extrinsic incubation of DENV-1 in the mosquito A.
aegypti. Ramirez et al. [50] found that A. aegypti mos-
quitoes infected with certain bacterial isolates from the
field were less susceptible to DENV infection.
In Africa, some mosquito populations have shown a
low vector competence to DENV, and according to some
authors, this low competence seems to somehow explain
the lower incidence of dengue on this continent; it is
also possible that cases have been underestimated, due
to the absence of diagnostic tools in the healthcare set-
ting on this continent [51].
Although the natural transovarial dengue virus trans-
mission may not be a rare event [52-54] and although the
dengue transmission in the island of Santiago may still be
active on a small scale, there were no positive pools for
the eggs collected in the field in this study, suggesting that
this is a very rare phenomenon in Cape Verde. With re-
spect to the low vector competence hypothesis, African
strains of A. aegypti, especially the subspecies A. aegypti
formosus and the species A. albopictus, exhibited lower
susceptibility to all four serotypes of DENV [14,15]. Bosio,
Beaty and Black [46] observed a higher midgut infection
Moura et al. Parasites & Vectors  (2015) 8:114 Page 8 of 9barrier (MIB) in A. aegypti formosus when compared with
the subspecies A. aegypti aegypti. According to the au-
thors, there is evidence that the frequency of the alleles
that control the MIB differ greatly between the two sub-
species. However, further studies are urgently needed to
better understand the transmission of DENV in Africa.
Conclusion
Although we could detect no DENV circulating in the
population of A. aegypti from Santiago Island, Cape
Verde, during an entomological surveillance in early
2014, our results indicate that this mosquito population
exhibits high vector competence for the DENV-2 and
DENV-3 strains and appears to be less susceptible to
DENV-1 and DENV-4. Viral RNA copies in the SG
remained relatively constant for at least 21 days after in-
fection, which may enhance the vector capacity of A.
aegypti. The results also suggest the presence of some
type of modulation mechanism of virus replication in
the salivary tissue.
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